Avanos Medical, Inc.
Avanos Medical, Inc. (AVNS) Revenue
Annual & quarterly revenue history · segment & region breakdown
AVNS · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsAvanos Medical, Inc. trailing twelve-month (TTM) revenue is $0.72B, an increase of 1.95% year-over-year from $0.70B in FY2025.
Revenue trend
2025 – 2011 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.70B | +$0.01B | +1.95% |
| 2024-12-31 | $0.69B | +$0.01B | +2.15% |
| 2023-12-31 | $0.67B | -$0.01B | -1.58% |
| 2022-12-31 | $0.68B | -$0.06B | -8.13% |
| 2021-12-31 | $0.74B | +$0.03B | +4.17% |
| 2020-12-31 | $0.71B | +$0.02B | +2.47% |
| 2019-12-31 | $0.70B | +$0.05B | +6.94% |
| 2018-12-31 | $0.65B | +$0.04B | +6.65% |
| 2017-12-31 | $0.61B | +$0.05B | +8.02% |
| 2016-12-31 | $0.57B | -$1.01B | -64.04% |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Avanos Medical, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Avanos Medical, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Avanos Medical, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
AVNS revenue · 4 questionsAVNS's trailing twelve-month (TTM) revenue is $0.72B. That is an increase of 1.95% year-over-year from $0.70B in FY2025.
▸ Source: FMP · Avanos Medical, Inc. SEC filings · GAAP · Avanos Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026